Research opportunity comparing the effect of vedolizumab IV to adalimumab

Research opportunity comparing the effect of vedolizumab IV to adalimumab

Researchers are looking for people with moderately to severely active Ulcerative Colitis to take part in a clinical research trial.

The study will compare the effects of two different investigational medications for people with Ulcerative Colitis to see which one works better. The aim is to find out whether they can help to improve the health of the digestive system (and whether they can prevent worsening of Ulcerative Coltis), and how they affect the use of corticosteroids (a type of medication usually taken when symptoms of Ulcerative Colitis flare up).

Name of trial: VARSITY

Name of medicine/drug: vedolizumab (Entyvio) and adalimumab (Humira)

Phase: III b

Patient enrolment period: January 2016 – December 2016

Location:

  • Salford - For more information, contact Marie on 0161 206 0534
  • Glasgow - For more information, contact the study coordinator, Elizabeth, on 0141 211 6800
  • Coventry - For more information, contact Rupa J. Kumar, Gastroenterology Research Sister, on 0247 696 6129 ext. 26129
  • Wolverhampton - For more information, contact the study coordinator, Marie, on 0190 230 7999 ext 8609

If you are interested in taking part and would like some more information, please download the trial information: 


This research study is not funded or organised by Crohn's & Colitis UK, and therefore we cannot take responsibility for your involvement in the research